$RUBY

Rubius Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Biotechnology

PRICE

$1.09 โ–ฒ0.926%

Extented Hours

VOLUME

1,077,468

DAY RANGE

0.9606 - 1.12

52 WEEK

0.9606 - 29.06

Join Discuss about RUBY with like-minded investors

profile
@NoobBot #Crypto4Noobs
recently

**@BillGates:** What a lovely bake, Ruby. You deserve a Paul Hollywood handshake for that one! https://t.co/XwRzaQwkNC https://twitter.com/BillGates/status/1509224891903479809

86 Replies 13 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@NoobBot #Crypto4Noobs
recently

Ruby on Rails creator backpedals about Bitcoin: 'We need crypto' https://cointelegraph.com/news/ruby-on-rails-creator-backpedals-about-bitcoin-we-need-crypto

124 Replies 15 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@Benlax #droscrew
recently

https://www.forbes.com/profile/ruby-lu/?sh=a1854c1ec804

85 Replies 11 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@Benlax #droscrew
recently

met with Ruby Lu today

130 Replies 11 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@DarkPoolAlgo #Dark Pool Charts
recently

SCAN RESULTS - BULLISH BOTTOMS $DISCA, $CHGG, $STNE, $ATVI, $PSX, $AZEK, $ETSY, $FTCH, $POSH, $UAA, $SNAP, $PFGC, $BMRN, $CAT, $BIGC, $AVLR, $RSX, $BKR, $COUP, $STNE, $LI, $LESL, $BMBL, $PTON, $IOVA, $RUBY TOPS $ATVI, $FTCH, $FVRR, $IFT, $SBH, $SONY, $YUM, $CVS, $NVST, $CAT, $SYK, $TDC, $TWLO, $RSX, $AMZN, $ALXN BEARISH $BK, $ELS, $KMX, $MCK, $NIO, $WFC, $NVDA, $TLT, $VALE, $INFY

60 Replies 10 ๐Ÿ‘ 9 ๐Ÿ”ฅ

SO
@soheil.n #StockTraders.NET
recently

watchlist: $AAL, $AMC, $JWN, $RUBY, $VIAC

119 Replies 6 ๐Ÿ‘ 6 ๐Ÿ”ฅ

BR
@brAli #StockTraders.NET
recently

why she up soo much RUBY

55 Replies 7 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

what is up with $RUBY?

44 Replies 13 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@thegiz18 #ivtrades
recently

Big turnaround in $RUBY on release of drug study from $24 to $14, trade what you see, not what you think

63 Replies 7 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@thegiz18 #ivtrades
recently

$RUBY up 35% ahead of drug study update today, worth watching move after release

129 Replies 12 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@Milpower1967 #ivtrades
recently

I have to run. Lunch date with missus. Sold the crap out of cash secured puts on $FTFT, $EBON, and $MARA after closing $RUBY CSPs.

54 Replies 15 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@Milpower1967 #ivtrades
recently

$RUBY finally paying off for me 65% profit and am closing at .45 and below. Bam.

136 Replies 12 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@Milpower1967 #ivtrades
recently

$RUBY 3/19 $7.50 and $5 puts are insane right now. All over the place and there is NO WAY they should be paying 35% for two weeks of holding. So, am watching and trying to scalp CSPs at both of those strikes.

44 Replies 13 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@Milpower1967 #ivtrades
recently

$RUBY is STILL misprinting it's 3/19 $7.50 puts. Price is UP today, yet the puts are also up. No. More shenanigans. Make them pay.

54 Replies 15 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@Milpower1967 #ivtrades
recently

Heads up $RUBY puts prices are wrong. No real change, yet puts increased in value. Am selling puts on it now.

93 Replies 11 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

covered rest of $RUBY and $VERU need a nap

59 Replies 14 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

Had some nice adds on $RUBY welp didnt alert was in a video call

65 Replies 6 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

$RUBY 8.8 is my target

131 Replies 6 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

I have half left $RUBY

112 Replies 12 ๐Ÿ‘ 8 ๐Ÿ”ฅ

WI
@WINTERTRADE #StockTraders.NET
recently

had a good avg on $ruby but all covered .. i dont know why i covered

137 Replies 13 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

cov 1/2 $RUBY

88 Replies 10 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

ss $RUBY starter

146 Replies 15 ๐Ÿ‘ 11 ๐Ÿ”ฅ

Key Metrics

Market Cap

91.12 M

Beta

2.08

Avg. Volume

1.77 M

Shares Outstanding

90.21 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-08

Next Dividend Date

Company Information

Rubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeuticsโ„ข. The Company's proprietary RED PLATFORMยฎ was designed to genetically engineer and culture Red Cell Therapeuticsโ„ข that are selective, potent and off-the-shelf allogeneic cellular therapies for the potential treatment of several diseases across multiple therapeutic areas.

CEO: Pablo Cagnoni

Website:

HQ: 399 Binney St Ste 300 Cambridge, 02142-1038 Massachusetts

Related News